Bone Biologics Corporation
BBLG · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $5 | $2 | $15 | $17 |
| - Cash | $6 | $7 | $3 | $3 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$1 | -$4 | $13 | $13 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | $0 | -$1 | -$1 | -$2 |
| % Margin | – | – | – | – |
| Net Income | -$1 | -$1 | -$1 | -$2 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.37 | -1.33 | -0.32 | -0.48 |
| % Growth | 72.2% | -315.6% | 33.3% | – |
| Operating Cash Flow | -$1 | -$0 | -$1 | -$1 |
| Capital Expenditures | $0 | -$0 | $0 | $0 |
| Free Cash Flow | -$1 | -$0 | -$1 | -$1 |